Valsartan Blood Pressure Drug Recall Widens

FDA.gov: “Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient.”

Article source: https://www.webmd.com/hypertension-high-blood-pressure/news/20181207/valsartan-blood-pressure-drug-recall-widens?src=RSS_PUBLIC

No comments yet.

Leave a Comment